The role of erythropoietin alginate/chitosan hydrogel on spinal cord injury in rats: A Stereological study

Subject Areas : Journal of Comparative Pathobiology

مهدی Gholami ¹ , حسن Gilanpour ² , جواد Sadeghinezhad ³

1 - Department of Basic Science and Hygiene, Faculty of veterinary medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 - Department of Basic Science and Hygiene, Faculty of veterinary medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran
3 - Department of Basic Science, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Received: 2022-09-05 Accepted : 2022-09-05 Published : 2022-02-20

Keywords: SCI, Stereology, hydrogel, Alginate and Chitosan, Erythropoietin, Thoracic Area,

Abstract :

Spinal cord injury (SCI) is a disabling neurological condition. In this study, first, the total volume of the thoracic spinal cord of healthy rats was calculated using stereology. In the next step, the volume of the thoracic spinal cord in the T9 area, the volume of the gray matter, white matter, vacuole, scar, and the locomotor function of animals after SCI were calculated. Erythropoietin (EPO) is a glycoprotein that protects cells in various tissues, including the spinal cord, by activating multiple signaling pathways. This study aimed to investigate the role of chitosan alginate hydrogel containing EPO on SCI. We observed that injured rats receiving EPO had improved functional recovery as assessed by the BBB Locomotor Rating in compared sham and negative control groups. Stereological estimates of the thoracic region show that the total volume of gray and white matter in the thoracic region of the rat averaged 126.2886 and 295.1914 mm3, respectively. The mean obtained from the dorsal horn in the thoracic part of the rat was 52.35028 mm3, and the abdominal horn was 60.79638 mm3, or in other words, the mean total volume of the thoracic spinal cord in the rat was 514.06 mm3. In the groups treated with a hydrogel, the amount of vacuole and scar in the spinal cord tissue was significantly reduced compared to the negative control group. Hydrogels containing EPO (1000 IU/kg) can significantly improve the tissue repair of the spinal cord at the injury site.

References:

1. Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front Neurol. 2019;10:282.


2. Jazayeri SB, Beygi S, Shokraneh F, Hagen EM, Rahimi-Movaghar V. Incidence of traumatic spinal cord injury worldwide: a systematic review. Eur Spine J. 2015;24(5):905-18.


3. Kang Y, Ding H, Zhou H, Wei Z, Liu L, Pan D, et al. Epidemiology of worldwide spinal cord injury: a literature review. Journal of Neurorestoratology. 2018;6(1):3.


4. Apuzzo ML. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery. 2002;50(3 Suppl):S63-S72.


5. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurgical review. 2004;27(2):113-20.


6. Marcos R, Monteiro RA, Rocha E. The use of design‐based stereology to evaluate volumes and numbers in the liver: a review with practical guidelines. Journal of anatomy. 2012;220(4):303-17.


7. Cho Y, Shi R, Borgens RB. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. Journal of experimental biology. 2010;213(9):1513-20.


8. Yao Z-a, Chen F-j, Cui H-l, Lin T, Guo N, Wu H-g. Efficacy of chitosan and sodium alginate scaffolds for repair of spinal cord injury in rats. Neural regeneration research. 2018;13(3):502.


9. Prang P, Müller R, Eljaouhari A, Heckmann K, Kunz W, Weber T, et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials. 2006;27(19):3560-9.


10. Gholami M, Gilanpour H, Sadeghinezhad J, Asghari A. Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats. DARU Journal of Pharmaceutical Sciences. 2021;29(2):255-65.


11. Acar N, Karakasli A, Karaarslan A, Mas NN, Hapa O. The reliability of Cavalier’s principle of stereological method in determining volumes of enchondromas using the computerized tomography tools. Journal of Orthopaedic Surgery. 2017;25(1):2309499016684503.


12. Khodabandeh Z, Mehrabani D, Dehghani F, Gashmardi N, Erfanizadeh M, Zare S, et al. Spinal cord injury repair using mesenchymal stem cells derived from bone marrow in mice: A stereological study. Acta histochemica. 2021;123(5):151720.


13. Sadeghinezhad J, Nyengaard JR. Morphometry of cervical spinal cord in cat using design‐based stereology. Anatomia, Histologia, Embryologia. 2021;50(4):746-55.


14. Sadeghinezhad J, Zadsar N, Hasanzadeh B. Morphometric changes in the spinal cord during prenatal life: a stereological study in sheep. Anatomical Science International. 2018;93(2):269-76.


15. Zhang H, Fang X, Huang D, Luo Q, Zheng M, Wang K, et al. Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro. Molecular Medicine Reports. 2018;17(1):264-72.

16. Mofidi A, Bader A, Pavlica S. The use of erythropoietin and its derivatives to treat spinal cord injury. Mini Reviews in Medicinal Chemistry. 2011;11(9):763-70.


17. Costa DD, Beghi E, Carignano P, Pagliacci C, Faccioli F, Pupillo E, et al. Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). Neurological Sciences. 2015;36(9):1567-74.


18. Nekoui A, Tresierra VDCE, Abdolmohammadi S, Shedid D, Blaise G. Neuroprotective effect of erythropoietin in postoperation cervical spinal cord injury: case report and review. Anesthesiology and pain medicine. 2015;5(6).